Inflammation increases sufentanil requirements during surgery for inflammatory bowel diseases

European Journal of Anaesthesiology

Volumn 20, Issue 12, 2003, Pages 957-962

  Guidat, A ^a   Fleyfel, M ^a   Vallet, B ^a   Desreumaux, P ^a   Levron, J C ^b   Gambiez, L ^a   Colombel, J F ^a   Scherpereel, P ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Janssen Research Foundation   (France)

Author keywords

Anaesthesia, General; Analgesics, opioids, sufentanil; Intestinal Diseases, inflammatory bowel disease, colitis, ulcerative, Crohn's disease; Somatosensory disorders, hyperalgesia; Surgical procedures, operative, intraoperative period

Indexed keywords

OROSOMUCOID; SUFENTANIL;

ABDOMINAL SURGERY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DRUG CLEARANCE; DRUG EFFECT; DRUG USE; ENTERITIS; HUMAN; HYPERALGESIA; INFLAMMATION; NOCICEPTIVE STIMULATION; PLASMA CLEARANCE; ULCERATIVE COLITIS;

EID: 0344197468     PISSN: 02650215     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0265021503001546     Document Type: Article

References (20)

1. Dray A. Inflammatory mediators of pain. Br J Anaesth 1995; 75: 125-131.
2. Levine J, Taiwo Y. Inflammatory pain. In: Wall PD, Melzack R, eds. Textbook of Pain, 4th edn. Edinburgh, UK: Churchill Livingstone, 1989: 45-56.
3. Maeyer EA, Gebhart GF. Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 1994; 107: 271-293.
4. Petit SH, Holbroock IB, Irving MH. Comparison of clinical scores and acute phase proteins in the assessment of acute Crohn's disease. Br J Surgery 1985; 72: 1013-1016.
5. Weeke B, Jarnum S. Serum concentration of 19 serum proteins in Crohn's disease and ulcerative colitis. Gut 1971; 12: 297-302.
6. Gesink-van der Veer BJ, Burm AGL, Vletter AA, Bovill JG. Influence of Crohn's disease on the pharmacokinetics and pharmacodynamics of alfentanil. Br J Anaesth 1993; 71: 827-834.
7. Best WR, Becktel JM, Singleton JW, Kern Jr F. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976; 70: 439-444.
8. Edwards RC, Truelove SC. The course and prognosis of ulcerative colitis. Parts I and II: Short term and long term prognosis. Gut 1963; 4: 299-308.
9. Michiels M, Hendriks R, Heykants J. Radioimmunoassay of the new opiate analgesics alfentanil and sufentanil. Preliminary pharmacokinetic profile in man. J Pharm Pharmacol 1983; 35: 86-93.
10. Brignola C, Campieri M, Bazzocchi G, Farruggia P, Tragnone A, Lanfranchi GA. A laboratory index for predicting relapse in asymptomatic patients with Crohn's disease. Gastroenterology 1986; 91: 1490-1494.
11. Mazlam MZ, Hodgson HJ. Interaction between interleukin-6, interleukin-1 beta, plasma C-reactive protein values, and in vitro C-reactive protein generation in patients with inflammatory bowel disease. Gut 1994; 35: 77-83.
12. Oldenburg B, van Kats-Renaud H, Koningsberger JC, van Berge Henegouwen GP, van Asbeck BS. Chemiluminescence in inflammatory bowel disease: a parameter of inflammatory activity. Clin Chim Acta 2001; 310: 151-156.
13. Betrz RJ, Granneman GR. Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interaction. Clin Pharmacokinet 1997; 32: 210-258.
14. Olstad OA, Skjelbred P. Comparison of the analgesic effect of a corticosteroid and paracetamol in patients with pain after oral surgery. Br J Clinic Pharmacol 1986; 22: 437-442.
15. Skjelbred P, Løkken P. Postoperative pain and inflammatory reaction reduced by injection of a corticosteroid. A controlled trial in bilateral oral surgery. Eur J Clin Pharmacol 1982; 21: 391-396.
16. Bueno L, Fioramonti J. Effects of inflammatory mediators on gut sensitivity. Can J Gastroenterol 1999; 13: 42A-46A.
17. Gebhart GF. Peripheral contributions to visceral hyperalgesia. Can J Gastroenterol 1999; 13: 37A-41A.
18. Gebhart GF. Visceral nociception: consequences, modulation and the future. Eur J Anaesthesiol 1995; 12: 24-27.
19. Giamberardino MA, Vecchiet L. Visceral pain, referred hyperalgesia and outcome: new concepts. Eur J Anaesthesiol 1995; 12: 61-66.
20. Verne GN, Robinson ME, Price DD. Hypersensitivity to visceral and cutaneous pain in the irritable bowel syndrome. Pain 2000; 93: 7-14.